PHN — Pharmanutra SpA Cashflow Statement
0.000.00%
Last trade - 00:00- €469.47m
- €475.92m
- €115.50m
- 95
- 18
- 30
- 42
Annual cashflow statement for Pharmanutra SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 14.1 | 13.8 | 15 | 12.8 | 16.6 |
| Depreciation | |||||
| Non-Cash Items | -0.795 | 1.49 | 2.31 | -2.85 | 1.25 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.82 | 3.76 | -4.21 | -1.01 | -1.23 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 11.8 | 20.4 | 14.5 | 12.1 | 20.5 |
| Capital Expenditures | -1.68 | -4.99 | -23.2 | -13.2 | -4.25 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.08 | -0.556 | -0.558 | -1.45 | 2.04 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.598 | -5.54 | -23.7 | -14.7 | -2.21 |
| Financing Cash Flow Items | 0.727 | -0.185 | -0.301 | -1.43 | -7.29 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -8.5 | -1.92 | 1.89 | -0.516 | -21.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.7 | 13 | -7.36 | -3.13 | -3.31 |